Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Current Pharmaceutical Biotechnology|December 8, 2010
Alpha7 neuronal nicotinic receptors as targets for novel therapies to treat multiple domains of schizophreniaAaron J Kucinski, Michal K Stachowiak, Scott R Wersinger, et al.The Journal of Pharmacology and Experimental Therapeutics|September 30, 2009
An alpha7 nicotinic acetylcholine receptor-selective agonist reduces weight gain and metabolic changes in a mouse model of diabetesMario B Marrero, Rudolf Lucas, Christina Salet, et al.Journal of Neuroscience Methods|February 21, 2012
A method for bidirectional solution exchange--"liquid bullet" applications of acetylcholine to α7 nicotinic receptorsNikolai Fedorov, Lisa Benson, John D Graef, et al.Journal of Biomolecular Screening|September 11, 2012
Validation of a high-throughput, automated electrophysiology platform for the screening of nicotinic agonists and antagonistsJohn D Graef, Lisa C Benson, Serguei S Sidach, et al.The Journal of Pharmacology and Experimental Therapeutics|September 27, 2012
Functional and structural interaction of (-)-reboxetine with the human α4β2 nicotinic acetylcholine receptorHugo R Arias, Nikolai B Fedorov, Lisa C Benson, et al.CNS Neuroscience & Therapeutics|December 2, 2008
TC-5214 (S-(+)-mecamylamine): a neuronal nicotinic receptor modulator with antidepressant activityPatrick M Lippiello, Jessica S Beaver, Gregory J Gatto, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 6, 2012
Analgesic effects mediated by neuronal nicotinic acetylcholine receptor agonists: correlation with desensitization of α4β2* receptorsJiahui Zhang, Yun-De Xiao, Kristen G Jordan, et al.Pageof 2